SciSparc Ltd. (SPRC)
SciSparc Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
SciSparc Ltd. (SPRC) is a Biotechnology company based in IL with a market capitalization of $274.7K. Revenue declined 34.5% year-over-year and free cash flow was negative at -$4.1M. This page tracks SPRC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
IL · 2 employees · IPO Aug 30, 2021
Valuation
Valuation & price
$4.82as of May 17, 2026· -92.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.06
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$274.7K
Market cap
-34.5%
Revenue growth (YoY)
73.7%
Gross margin
-$4.1M
Free cash flow (USD)
-$4.2M
Net debt
Net cash position
2031.9%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
1
Insider sells · 90 days
Earnings
Last report: 20-F filed Apr 29, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 6-K filingJul 15, 2026Filing
Clinical Trial Initiation
- 6-K filingJun 4, 2026Filing
Acquisition Completed
- Insider sellJun 3, 2026Filing
Insider Sell $5KShrem Itschak · Director · $4.6K
- 6-K filingMay 29, 2026Filing
Amendment to Share Purchase Agreement
- 6-K filingMay 11, 2026Filing
Regulatory Update
- Annual reportApr 29, 2026Filing
20-F Filed
Questions
Frequently asked questions
What is SciSparc Ltd.'s market cap?
SciSparc Ltd. (SPRC) has a market capitalization of $274.7K.
What is SPRC's P/E ratio?
A meaningful P/E ratio is not available for SPRC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is SPRC's price-to-book (P/B) ratio?
SPRC trades at 0.06 times book value per share.
Are insiders buying SPRC stock?
SEC Form 4 filings show no open-market insider buys at SciSparc Ltd. in the last 90 days (1 sell).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.